| Literature DB >> 36127398 |
Masayuki Komatsu1, Hitoshi Ichikawa2, Fumiko Chiwaki3, Hiromi Sakamoto2, Rie Komatsuzaki4, Makoto Asaumi5, Kazuhisa Tsunoyama5, Takeo Fukagawa6, Hiromichi Matsushita7, Narikazu Boku8, Keisuke Matsusaki9, Fumitaka Takeshita3, Teruhiko Yoshida10, Hiroki Sasaki11.
Abstract
Genetic alteration of Rho GTPase-activating proteins (ARHGAP) and GTPase RhoA is a hallmark of diffuse-type gastric cancer and elucidating its biological significance is critical to comprehensively understanding this malignancy. Here, we report that gene fusions of ARHGAP6/ARHGAP26 are frequent genetic events in peritoneally-metastasized gastric and pancreatic cancer. From the malignant ascites of patients, we established gastric cancer cell lines that spontaneously gain hotspot RHOA mutations or four different ARHGAP6/ARHGAP26 fusions. These alterations critically downregulate RhoA-ROCK-MLC2 signaling, which elicits cell death. Omics and functional analyses revealed that the downstream signaling initiates actin stress fibers and reinforces intercellular junctions via several types of catenin. E-cadherin-centered homotypic adhesion followed by lysosomal membrane permeabilization is a pivotal mechanism in cell death. These findings support the tumor-suppressive nature of ARHGAP-RhoA signaling and might indicate a new avenue of drug discovery against this refractory cancer.Entities:
Year: 2022 PMID: 36127398 DOI: 10.1038/s41388-022-02469-6
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 8.756